| Literature DB >> 31979027 |
Dong Ju Son1, Jae Chul Jung2, Yong Min Choi2, Hyeon Yeol Ryu3, Somin Lee3, Barbara A Davis4.
Abstract
The efficacy of wheat extract oil (WEO), standardized to glucosylceramides, for protecting against ultraviolet B (UVB)-induced damage of skin barrier function was assessed using the SHK-1 hairless mouse model and two human skin cell lines, namely, CCD-986sk and HeCaT. The ability of repeated oral administration of 30, 60, and 120 mg of WEO/kg/day for 12 weeks to prevent skin damage of SKH-1 hairless mice induced by UVB irradiation was evaluated. The results demonstrated that UVB-induced water evaporation (transepidermal water loss, TEWL) was significantly decreased by WEO. Similarly, UVB-induced losses in moisture and skin elasticity were improved by WEO supplementation. WEO attenuated the tissue procollagen type I, hyaluronic acid (HA), and ceramide reductions induced by UVB treatment as well. Collagen concentrations in skin tissue were increased in the WEO-treated mice, while UVB-induced epidermal thickening was reduced. In vitro studies using HeCaT human keratinocytes confirmed increased HA and collagen synthesis in response to WEO treatment. This may occur via WEO suppression of matrix metallopeptidase-1 (MMP-1), since its induction by UVB treatment was diminished in treated CCD-986sk cells. Oral administration of WEO improves skin barrier function in UVB-irradiated mice by attenuating damage typically observed in photoaging. This research further clarifies the clinical benefits previously observed by dietary WEO consumption.Entities:
Keywords: collagen; hairless mice; hydration; photoaging; polar lipids; wheat (Triticum vulgare/aestivum)
Year: 2020 PMID: 31979027 PMCID: PMC7070621 DOI: 10.3390/nu12020300
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Treatment groups.
| Group | Volume (mg/kg) | |
|---|---|---|
|
| Normal control group | 0 |
|
| UVB control group | 0 |
|
| UVB + WEO | 30 |
|
| 60 | |
|
| 120 | |
|
| UVB + Positive control (HA) | 60 |
Abbreviations: UVB—ultraviolet B; WEO—wheat extract oil; HA—hyaluronic acid.
Figure 1WEO-induced changes in skin surface condition at week 12. (A) Skin moisture measurement by Corneometer CM825. (B) Transepidermal water loss measurement by Tewameter TM 300. (C) Skin elasticity measurement by Cutometer MPA580. (D) Roughness measurement by Visioscan VC98. Values with different letters are significantly different by analysis of variance (ANOVA) followed by the Newman– Keuls multiple range test (p < 0.05). NC: normal control, UVB: Ultraviolet, WEO: wheat extract oil, HA: Hyaluronic acid.
Figure 2Effect of WEO on skin tissue components at 12 weeks. (A) Procollagen type I measurement by ELISA. (B) Hyaluronic acid measurement by ELISA. (C) Ceramide measurement by LC/MS/MS. (D) Collagen measurement by Masson’s trichrome stain. Values with different letters are significantly different by ANOVA followed by the Newman–Keuls multiple range test (p < 0.05). NC: normal control, UVB: Ultraviolet, WEO: wheat extract oil, HA: Hyaluronic acid.
Figure 3Epidermis thickness measurement (Masson’s trichome stain) at week 12. Values with different letters are significantly different by ANOVA followed by the Newman–Keuls multiple range test (p < 0.05). NC: normal control, UVB: Ultraviolet, WEO: wheat extract oil, HA: Hyaluronic acid.
Figure 4Changes in skin-damage-related factors in human skin cell lines. (A) Procollagen synthetic enhancement measurement in CCD-986sk cells by microplate reader. (B) Hyaluronic acid measurement in HaCaT cells. (C) Measurement of matrix metalloproteinase-1 (MMP-1) mRNA expression in CCD-986sk cells by qRT-PCR. Values with different letters are significantly different by ANOVA followed by the Newman–Keuls multiple range test (p < 0.05). NC: normal control, UVB: Ultraviolet, WEO: wheat extract oil, HA: Hyaluronic acid.